American Cancer Society Journals Highlight New Evidence for PSA-Based Prostate Cancer Screening
American Cancer Society Journals/LinkedIn

American Cancer Society Journals Highlight New Evidence for PSA-Based Prostate Cancer Screening

American Cancer Society Journals shared on LinkedIn:

“New today: The American Cancer Society (ACS) has updated its guideline for prostate cancer screening in an effort to help find the cancer before it spreads and reduce the risk of dying from the disease. The guideline update is published in a report in CA: A Cancer Journal for Clinicians, the flagship journal of ACS.

Who should get screened?

  • Regular screening is recommended with a prostate-specific antigen (PSA)-based test every two years for average-risk men aged 50 – 69.
  • Annual PSA-based screening is recommended beginning at age 45 for men who are at higher risk, including Black men and men with a family history of prostate cancer.
  • Individualized decision-making on continuing screening is recommended for men aged 70 to 74 years, as the balance of benefits and harms remains uncertain.
  • Screening is not recommended for men aged 75 years and older. Some men ages 75 to 79 who are very healthy may want to continue screening, especially if their PSA has been rising on previous tests. But this should be discussed with a healthcare provider.
  • Screening is not recommended for men aged 80 and older, and for men who are not expected to live another ten years.

Since the previous ACS guideline was published in 2010, there is stronger evidence showing that screening for prostate cancer with a PSA test significantly reduces prostate cancer mortality and diagnosis of advanced-stage disease. The changes to the guideline reflect stronger evidence of the benefits of PSA-based screening combined with the increasing use of management strategies that can reduce harms such as unnecessary biopsies and treatment.”

Title: American Cancer Society guideline for the early detection of prostate cancer, 2026

Authors: Richard M. Hoffman, Andrew M. D. Wolf, Ruth D. Etzioni, Kevin C. Oeffinger, Sana Raoof, Louise C. Walter, Charnita Zeigler-Johnson, Timothy R. Church, Christopher K. Jones, Artie L. Shelton, Elena B. Elkin, Carmen E. Guerra, Rebecca B. Perkins, Ya-Chen Tina Shih, Steven J. Skates, Roman Gulati, Hormuzd A. Katki, Tyler B. Kratzer, Deana Manassaram-Baptiste, William L. Dahut, Robert A. Smith

Read the full article. 

You can also read:

New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing

American Cancer Society Journals Highlight New Evidence for PSA-Based Prostate Cancer Screening